BG Medicine (NASDAQ: BGMD) Stock Declines | Earnings Report Released


BGMD Stock NewsBG Medicine, Inc. (NASDAQ: BGMD)

BG Medicine stocks fell in a big way in morning trading today after the company released its earnings report before the bell. While the report showed that earnings did beat analyst expectations, investors seemed to be unhappy with the results.

BGMD Earnings Report

Here are the key highlights from the BG Medicine earnings report…

  • Earnings Per Share – In the quarter, BG Medicine produced a loss of $0.04 per share; beating analyst expectations of a $0.05 per share loss. Last year’s report for the same quarter showed a loss of $0.06 per share.
  • Full Year – For the full year of 2014, BGMD produced a loss of $8.1 million; a 49% improvement when compared to 2014.
  • Operating Expenses – Year over year, operating expenses declined by 46%.

For a more detailed analysis of the BGMD earnings report, click here.

How BG Medicine Stock Reacted

Usually, when a company beats expectations with regard to their earnings report, we see growth in the value of the stock. Unfortunately for BG Medicine, that’s not what happened today. Currently (12:50), BGMD is trading at $0.81 per share after a loss of 14.34% so far today.

What We Can Expect To See Moving Forward

While the stock is down today, I can understand that. After all, no investor likes losses. However, I think this earnings report was a positive thing. It showed that the company is improving, that losses are declining, and that operational expenses are down. Overall, that means that the company is positioning itself very well for growth moving forward. Although the stock will likely close in the red today, I’m expecting to start to see growth over the next week or two.

What Do You think?

Where do you think BGMD is headed? Let us know in the comments below!


Please enter your comment!
Please enter your name here